Cargando…

Status Construction During COVID-19: Antibody Positive People's Rising Prestige

The protracted COVID-19 crisis provides a new social niche in which new inequalities can emerge. We provide predictions about one such new inequality using the logic of Status Construction Theory (SCT). SCT, rooted in Expectations State Theory and from there developed by Ridgeway and colleagues, pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Evans, M. D. R., Kelley, Jonathan, Kelley, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022745/
https://www.ncbi.nlm.nih.gov/pubmed/33869503
http://dx.doi.org/10.3389/fsoc.2020.576827
_version_ 1783674996733771776
author Evans, M. D. R.
Kelley, Jonathan
Kelley, Sarah
author_facet Evans, M. D. R.
Kelley, Jonathan
Kelley, Sarah
author_sort Evans, M. D. R.
collection PubMed
description The protracted COVID-19 crisis provides a new social niche in which new inequalities can emerge. We provide predictions about one such new inequality using the logic of Status Construction Theory (SCT). SCT, rooted in Expectations State Theory and from there developed by Ridgeway and colleagues, proposes general hypotheses about how new inequalities arise through process of interaction at the individual level: an unordered categorical difference becomes attached to a cultural value that gives one category more value than the other; social scripts concerning it emerge; small elements of assertion and deference creep into more and more encounters that an individual participates in, hears about through networks, and learns about via social and conventional media. The categorical difference begins to morph into a hierarchical status distinction. Through these mechanisms, individuals develop “status beliefs” that most people in their communities endorse the status distinction. Although they may or may not endorse the distinction personally, they believe that most people do so and they find that the path of least resistance socially is to enact the scripts that affirm the higher status/prestige of the favored group. We apply Status Construction Theory to the categorical difference between Antibody Positives (who have been tested for IgG antibodies) and Others (everybody else). Using the general logic of SCT and specifically developing applications of its key propositions, we predict that the categorical difference between Antibody Positives and Others will transition to a status distinction and propose testable, falsifiable hypotheses about each step of the process.
format Online
Article
Text
id pubmed-8022745
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80227452021-04-15 Status Construction During COVID-19: Antibody Positive People's Rising Prestige Evans, M. D. R. Kelley, Jonathan Kelley, Sarah Front Sociol Sociology The protracted COVID-19 crisis provides a new social niche in which new inequalities can emerge. We provide predictions about one such new inequality using the logic of Status Construction Theory (SCT). SCT, rooted in Expectations State Theory and from there developed by Ridgeway and colleagues, proposes general hypotheses about how new inequalities arise through process of interaction at the individual level: an unordered categorical difference becomes attached to a cultural value that gives one category more value than the other; social scripts concerning it emerge; small elements of assertion and deference creep into more and more encounters that an individual participates in, hears about through networks, and learns about via social and conventional media. The categorical difference begins to morph into a hierarchical status distinction. Through these mechanisms, individuals develop “status beliefs” that most people in their communities endorse the status distinction. Although they may or may not endorse the distinction personally, they believe that most people do so and they find that the path of least resistance socially is to enact the scripts that affirm the higher status/prestige of the favored group. We apply Status Construction Theory to the categorical difference between Antibody Positives (who have been tested for IgG antibodies) and Others (everybody else). Using the general logic of SCT and specifically developing applications of its key propositions, we predict that the categorical difference between Antibody Positives and Others will transition to a status distinction and propose testable, falsifiable hypotheses about each step of the process. Frontiers Media S.A. 2020-12-22 /pmc/articles/PMC8022745/ /pubmed/33869503 http://dx.doi.org/10.3389/fsoc.2020.576827 Text en Copyright © 2020 Evans, Kelley and Kelley. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Sociology
Evans, M. D. R.
Kelley, Jonathan
Kelley, Sarah
Status Construction During COVID-19: Antibody Positive People's Rising Prestige
title Status Construction During COVID-19: Antibody Positive People's Rising Prestige
title_full Status Construction During COVID-19: Antibody Positive People's Rising Prestige
title_fullStr Status Construction During COVID-19: Antibody Positive People's Rising Prestige
title_full_unstemmed Status Construction During COVID-19: Antibody Positive People's Rising Prestige
title_short Status Construction During COVID-19: Antibody Positive People's Rising Prestige
title_sort status construction during covid-19: antibody positive people's rising prestige
topic Sociology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022745/
https://www.ncbi.nlm.nih.gov/pubmed/33869503
http://dx.doi.org/10.3389/fsoc.2020.576827
work_keys_str_mv AT evansmdr statusconstructionduringcovid19antibodypositivepeoplesrisingprestige
AT kelleyjonathan statusconstructionduringcovid19antibodypositivepeoplesrisingprestige
AT kelleysarah statusconstructionduringcovid19antibodypositivepeoplesrisingprestige